SG
CNCR
StoneX Group’s ETF Series Solutions Trust Range Cancer Therapeutics ETF CNCR Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | – | Sell |
-16,565
| Closed | -$350K | – | 258 |
|
|
2019
Q2 | $350K | Sell |
16,565
-518
| -3% | -$10.9K | 0.22% | 144 |
|
|
2019
Q1 | $359K | Sell |
17,083
-305
| -2% | -$6.41K | 0.27% | 128 |
|
|
2018
Q4 | $328K | Sell |
17,388
-700
| -4% | -$13.2K | 0.32% | 116 |
|
|
2018
Q3 | $449K | Buy |
18,088
+463
| +3% | +$11.5K | 0.33% | 99 |
|
|
2018
Q2 | $425K | Buy |
17,625
+810
| +5% | +$19.5K | 0.37% | 99 |
|
|
2018
Q1 | $488K | Buy |
16,815
+2,002
| +14% | +$58.1K | 0.47% | 70 |
|
|
2017
Q4 | $352K | Buy |
14,813
+2,286
| +18% | +$54.3K | 0.37% | 104 |
|
|
2017
Q3 | $339K | Buy |
12,527
+638
| +5% | +$17.3K | 0.42% | 98 |
|
|
2017
Q2 | $274K | Buy |
+11,889
| New | +$274K | 0.09% | 302 |
|